These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 365325)

  • 1. Preliminary report of the use of levamisole in the treatment of bladder cancer.
    Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
    Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.
    Smith RB; Dekernion J; Baron B; Skinner DG; Kaufman JJ
    J Urol; 1978 Mar; 119(3):347-9. PubMed ID: 347106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
    Nathanson SD; Zamfirescu PL; Portaro JK; deKernion JB; Fahey JL
    J Natl Cancer Inst; 1978 Aug; 61(2):301-6. PubMed ID: 355647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
    Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
    Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole: a double blind immunological study.
    Webster DJ; Whitehead RH; Richardson G; Hughes LE
    Anticancer Res; 1982; 2(1-2):29-32. PubMed ID: 7051958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M; Saint F; Chopin D; Malavaud B; Nicolas L; Rischmann P
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.
    Gonzalez RL; Spitler LE; Sagebiel RW
    Cancer Treat Rep; 1978 Nov; 62(11):1703-7. PubMed ID: 365324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in squamous cell carcinoma of the head and neck.
    Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
    Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
    Cai T; Nesi G; Tinacci G; Zini E; Mondaini N; Boddi V; Mazzoli S; Bartoletti R
    J Urol; 2008 Jul; 180(1):110-5. PubMed ID: 18485394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
    de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
    J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.
    Palou J; Laguna P; Millán-Rodríguez F; Hall RR; Salvador-Bayarri J; Vicente-Rodríguez J
    J Urol; 2001 May; 165(5):1488-91. PubMed ID: 11342902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.
    Hurle R; Losa A; Ranieri A; Graziotti P; Lembo A
    J Urol; 1996 Nov; 156(5):1602-5. PubMed ID: 8863547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
    Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
    Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
    Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
    Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.